The company was founded in December 2000 and is a national high-tech enterprise, a national high-tech industrialization demonstration project, and a national resource comprehensive utilization project. The company was listed on the Shenzhen Stock Exchange GEM on October 9, 2014. The company's main business is the vitamin sector and pharmaceutical manufacturing sector. The main products are lanolin cholesterol, vitamin D3, 25-hydroxyvitamin D3, vitamin A, valsartan amlodipine tablets (I), doxofloxacin injections, lipoic acid injections, escitalopram tablets, omeprazole sodium bicarbonate capsules, dopazepine tablets, amlodipine atorvastatin calcium tablets, roxithromycin tablets, alendronate tablets, etc. Corporate honors: high-tech enterprises, key high-tech enterprises of the National Torch Program, China Patent Excellence Award, National Science and Technology Progress Award, etc.